Today the Senate Committee on Appropriations approved a bill that would boost U.S. government funding for Alzheimer’s disease to almost $1.4 billion in fiscal year 2017. Post navigationPreviousPrevious post:Does Mild Behavioral Impairment Precede MCI? Review the AAIC 2016 “MBI” Checklist Report.NextNext post:Science of Translational Medicine: New in vivo data published on beta amyloid as a protectant against pathogens